首页> 外文期刊>Journal of Labelled Compounds and Radiopharmaceuticals >Synthesis of a radioiodinated thymidine phosphorylase inhibitor and its preliminary evaluation as a potential SPECT tracer for angiogenic enzyme expression
【24h】

Synthesis of a radioiodinated thymidine phosphorylase inhibitor and its preliminary evaluation as a potential SPECT tracer for angiogenic enzyme expression

机译:放射性碘化胸苷磷酸化酶抑制剂的合成及其作为潜在的SPECT示踪剂用于血管生成酶表达的初步评估

获取原文
获取原文并翻译 | 示例
           

摘要

The expression of thymidine phosphorylase (TP) is strongly associated with angiogenesis in tumors and activation of antitumor agents. We designed a novel 5-~(125)I-labeled 6-(2-iminoimidazolidinyl)methyluracil hydrochloride ([~(125)I]5I6IMU-HCI) to develop an effective radiotracer for in vivo assessment of TP expression in tumors and prognosis of cancer chemotherapy. Radiotracer synthesis was achieved by radioiodination of the precursor, 6-(2-iminoimidazolidinyl)methylur-acil at the C-5 position with NCS/radioiodide. After purification by HPLC, [~(125)I]5I6IMU-HCI was obtained in high radiochemical yield with satisfactory specific activity. The radiotracer showed high inhibitory potency for the target enzyme and good stability in vivo.
机译:胸苷磷酸化酶(TP)的表达与肿瘤中的血管生成和抗肿瘤药的激活密切相关。我们设计了一种新型的5-〜(125)I标记的6-(2-亚氨基咪唑啉基)甲基尿嘧啶盐酸盐([〜(125)I] 5I6IMU-HCI),以开发一种有效的放射性示踪剂,用于体内评估肿瘤中TP的表达和预后。癌症化疗。放射性示踪剂的合成是通过用NCS /放射性碘化物对C-5位的前体6-(2-亚氨基咪唑啉基)甲基尿嘧啶进行碘化来实现的。通过HPLC纯化后,以高放射化学产率获得具有令人满意的比活的[〜(125)I] 5I6IMU-HCl。放射性示踪剂显示出对靶酶的高抑制力和体内良好的稳定性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号